市場調查報告書

靜脈瘤治療市場:各產品(射頻消融術設備,雷射消熔設備,其他),不同治療(硬化療法,靜脈內切除,其他),不同地區的預測

Varicose Vein Treatment Market: By treatment Types, By Device; By End-User industry: Geographic Analysis - Forecast 2018-2023

出版商 IndustryARC 商品編碼 422786
出版日期 內容資訊 英文 120 Pages
商品交期: 2-3個工作天內
價格
Back to Top
靜脈瘤治療市場:各產品(射頻消融術設備,雷射消熔設備,其他),不同治療(硬化療法,靜脈內切除,其他),不同地區的預測 Varicose Vein Treatment Market: By treatment Types, By Device; By End-User industry: Geographic Analysis - Forecast 2018-2023
出版日期: 2018年12月20日內容資訊: 英文 120 Pages
簡介

本報告提供全球靜脈瘤治療市場相關調查,彙整市場現狀與未來發展預測,各產品,不同治療,各地區趨勢,打入市場的主要企業簡介等資料。

第1章 概要

第2章 摘要整理

第3章 市場情況

  • 市場佔有率分析
  • 競爭分析
  • 產品基準
  • 終端用戶分析
  • 主要5公司的財務分析

第4章 市場力量

  • 促進要素
  • 阻礙要素
  • 機會
  • 課題
  • 波特五力分析

第5章 策略性分析

  • 價值鏈分析
  • 價格分析
  • 機會分析
  • 產品/市場生命週期分析
  • 供給者和經銷商

第6章 各產品市場

  • 射頻消融術設備
  • 雷射消熔設備
  • 靜脈縫合產品
  • 外科產品

第7章 不同治療市場

  • 硬化療法
  • 靜脈內切除
  • 汽提
  • 雷射
  • 射頻消融術

第8章 各地區市場

  • 歐洲
  • 亞太地區
  • 北美
  • 其他

第9章 熵

  • 擴充
  • 技術發展
  • 合併·收購,合資企業
  • 供給契約

第10章 企業簡介

第11章 附錄

本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

目錄

Varicose Vein Treatment market Overview:

Varicose Vein is a vein disorder where the veins gnarled and enlarged. The varicose veins generally appear in the lower limbs of the human body. The varicose vein treatment market consists of various treatment procedures such as radiofrequency ablation, laser therapy and so on. The global varicose vein treatment market is growing at CAGR 5.09% and the global market revenue is $ 325 million in 2018 and it is forecasted to reach $ 416 million by 2023.

Varicose Vein Treatment market Outlook:

Varicose veins are caused when the veins in the lower limbs do not allow the blood flow effectively. This condition in veins cause swelling, aching and pain in legs. Varicose veins can be classified into trunk varicose veins, reticular varicose veins and telangiectasia varicose veins. The treatment for varicose veins can be given in various methods like radiofrequency ability, laser therapy and sclerotherapy. . The end users for varicose vein treatment market are segmented as surgery centers and hospitals.

Varicose Vein Treatment market Growth drivers:

One of the major drivers in this industry is the prevalence of varicose veins is high in women. It is more common in older women. The risk of having varicose veins is more in pregnant women and in women who take menopausal hormone therapy. It is reported that women have twice the risk of having varicose veins when compared to men.

Varicose Vein Treatment market Challenges:

The major challenge in this industry is neovascularization, a process where regrowth of veins takes place. There are chances that even after a surgery, the varicose veins might regrow. Sometimes varicose veins might develop in other parts of the legs.

Varicose Vein Treatment Market

Varicose Vein Treatment market Research Scope:

The base year of the study is 2017, with forecast done up to 2023. The study presents a thorough analysis of the competitive landscape, taking into account the market shares of the leading companies. It also provides information on unit shipments. These provide the key market participants with the necessary business intelligence and help them understand the future of the Varicose Vein Treatment market. The assessment includes the forecast, an overview of the competitive structure, the market shares of the competitors, as well as the market trends, market demands, market drivers, market challenges, and product analysis. The market drivers and restraints have been assessed to fathom their impact over the forecast period. This report further identifies the key opportunities for growth while also detailing the key challenges and possible threats.

Varicose Vein Treatment (SAP) Market Report: Industry Coverage:

Varicose Vein Treatment market - By treatment Types: surgical treatments: Vein ligation and stripping, phlebectomy; non-surgical treatments: Laser Therapy, trans-illuminated powered phebectomy (trivex), Radiofrequency ablation; Sclerotherapy.

Varicose Vein Treatment market - By Device: Ablation devices: Radiofrequency Ablation Devices, Laser Ablation Devices; Venous Closure Products, Surgical Products.

Varicose Vein Treatment market - By End-User industry: Healthcare Industry: Surgery centers, Hospitals: Specialty hospitals, Multispecialty hospitals

The Varicose Vein Treatment market report also analyzes the major geographic regions for the market as well as the major countries for the market in these regions. The regions and countries covered in the study include:

North America: The U.S., Canada, Mexico

South America: Brazil, Venezuela, Argentina, Ecuador, Peru, Colombia, Costa Rica

Europe: The U.K., Germany, Italy, France, The Netherlands, Belgium, Spain, Denmark

APAC: China, Japan, Australia, South Korea, India, Taiwan, Malaysia, Hong Kong

Middle East and Africa: Israel, South Africa, Saudi Arabia

Varicose Vein Treatment market Key Players Perspective:

Some of the Key players in this market are Angiodynamics Inc, Biolitec AG, BTG Plc, Energist Medical Solutions, Eufoton S.R.L, Lumenis Ltd, Medtronic Inc., Quanta System S.p.A, Syneron Medical Ltd, and Vascular Solutions Inc. among others.

Market Research and Market Trends of Varicose Vein Treatment market:

Syneron Candela has been acquired by Apax partners. The Israel based non-surgical aesthetic device manufacturer has become a private company after its acquisition by an affiliate by funds for $11.00 per share was advised by Apax partners. It is reported that the transaction for acquiring Syneron candela was valued at approximately $400 million. This acquisition expands Apax Partners' investments in Healthcare industry.

Biolitec GmbH has launched a laser therapy product named LEONARDO mini and it is reported that this product can carry out laser treatment for varicose veins. The product weighs only 900 grams and it is available in two wavelengths (980nm and 1470nm).

BTG plc has acquired Novate medical ltd, a medical device manufacturer. BTG plc has paid $20 million in cash and it might be required to pay additional cash considerations up to $130 million if few commercial and sales related milestones are met.

Health Canada has approved Varithena, a drug and device combination product used to treat varicose veins. The product from BTG plc is intended to treat venous reflux. Varithena consists of polidocanol injectable foam.

1. Varicose Vein Treatment Market - Overview

2. Executive Summary

3. Varicose Vein Treatment Market Landscape

  • 3.1. Market Share Analysis
  • 3.2. Comparative Analysis
  • 3.3. Product Benchmarking
  • 3.4. End User Profiling
  • 3.5. Top 5 Financials Analysis

4. Varicose Vein Treatment Market- Forces

  • 4.1. Drivers
    • 4.1.1. Development of advance and progressively less-invasive treatment procedures
    • 4.1.2. Growing incidence of varicose veins
  • 4.2. Restraints
    • 4.2.1. Higher cost of varicose vein treatment procedures
  • 4.3. Opportunities
    • 4.3.1. Emerging economies
  • 4.4. Challenges
  • 4.5. Porter's Five Forces Analysis
    • 4.5.1. Bargaining Power of Suppliers
    • 4.5.2. Bargaining Power of Buyers
    • 4.5.3. Threat of New Entrants
    • 4.5.4. Threat of Substitutes
    • 4.5.5. Degree of Competition

5. Varicose Vein Treatment Market- Strategic Analysis

  • 5.1. Value Chain Analysis
  • 5.2. Pricing Analysis
  • 5.3. Opportunities Analysis
  • 5.4. Product/Market Life Cycle Analysis
  • 5.5. Suppliers and Distributors

6. Varicose Vein Treatment Market, By Product

  • 6.1. Radiofrequency Ablation Devices
  • 6.2. Laser Ablation Devices
  • 6.3. Venous Closure Products
  • 6.4. Surgical Products

7. Varicose Vein Treatment Market, By Treatment

  • 7.1. Sclerotherapy
  • 7.2. Endovenous Ablation
  • 7.3. Stripping
  • 7.4. Laser
  • 7.5. Radiofrequency Ablation

8. Varicose Vein Treatment Market, By Geography

  • 8.1. Europe
    • 8.1.1. Germany
    • 8.1.2. France
    • 8.1.3. Italy
    • 8.1.4. Spain
    • 8.1.5. Russia
    • 8.1.6. U.K.
    • 8.1.7. Rest of Europe
  • 8.2. Asia Pacific
    • 8.2.1. China
    • 8.2.2. India
    • 8.2.3. Japan
    • 8.2.4. South Korea
    • 8.2.5. Rest of Asia-Pacific
  • 8.3. North America
    • 8.3.1. U.S.
    • 8.3.2. Canada
    • 8.3.3. Mexico
  • 8.4. Rest of the World (RoW)
    • 8.4.1. Brazil
    • 8.4.2. Rest of RoW

9. Varicose Vein Treatment - Entropy

  • 9.1. Expansion
  • 9.2. Technological Developments
  • 9.3. Merger & Acquisitions, and Joint Ventures
  • 9.4. Supply- Contract

10. Company Profiles (Overview, Financials, SWOT Analysis, Developments, Product Portfolio)

  • 10.1. Vascular Solutions, Inc.
  • 10.2. Syneron Medical Ltd.
  • 10.3. Lumenis Ltd.
  • 10.4. Dornier MedTech GmbH
  • 10.5. Quanta Systems S.p.A.
  • 10.6. Medtronic plc
  • 10.7. AngioDynamics, Inc.
  • 10.8. Biolitec AG
  • 10.9. Energist Group
  • 10.10. Eufoton S.R.L

More than 40 Companies are profiled in this Research Report, Complete List available on Request*

"*Financials would be provided on a best efforts basis for private companies"

11. Appendix

  • 11.1. Abbreviations
  • 11.2. Sources
  • 11.3. Research Methodology
  • 11.4. Bibliography
  • 11.5. Compilation of Expert Insights
  • 11.6. Disclaimer
Back to Top